English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/158429
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Saccharomyces cerevisiae show low levels of traversal across human endothelial barrier in vitro

AuthorsPérez Torrado, Roberto ; Querol, Amparo
Issue Date20-Jun-2017
PublisherFaculty of 1000
CitationF1000Research 6: 944 (2017)
Abstract[Background]: Saccharomyces cerevisiae is generally considered safe, and is involved in the production of many types of foods and dietary supplements. However, some isolates, which are genetically related to strains used in brewing and baking, have shown virulent traits, being able to produce infections in humans, mainly in immunodeficient patients. This can lead to systemic infections in humans. [Methods]: In this work, we studied S. cerevisiae isolates in an in vitro human endothelial barrier model, comparing their behaviour with that of several strains of the related pathogens Candida glabrata and Candida albicans. [Results]: The results showed that this food related yeast is able to cross the endothelial barrier in vitro. However, in contrast to C. glabrata and C. albicans, S. cerevisiae showed very low levels of traversal. [Conclusions]: We conclude that using an in vitro human endothelial barrier model with S. cerevisiae can be useful to evaluate the safety of S. cerevisiae strains isolated from foods.
Publisher version (URL)http://dx.doi.org/10.12688/f1000research.11782.2
URIhttp://hdl.handle.net/10261/158429
DOI10.12688/f1000research.11782.2
E-ISSN2046-1402
Appears in Collections:(IATA) Artículos
Files in This Item:
File Description SizeFormat 
F1000Research-2017-Perez-torrado.pdfArtículo principal640,85 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.